Weight loss and type II diabetes control after Laparoscopic Sleeve Gastrectomy in an early post-operative period - A prospective cohort study

Kumar, Sanjeev; Ansari, Abu Masud; Verma, Umakant; Kumar, Naveen; Dixit, Priyadarshi

doi:10.1007/s13126-016-0342-6

Cited by 1 publication

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Significant improvement of plasma glucose level control, and/or resolution of type 2 diabetes mellitus (as evident by diabetic markers like fasting as well as post prandial plasma glucose levels, and HbA1c), is commonly observed after LSG [14] . After 12 months, a remission of type 2 diabetes mellitus after LSG was 57.7% as reported by Peterli et al, [15] , 80.9% as reported by Abbatini et al, [16] , 78.6% as reported by Yang et al, [17] , and 84.6% as reported by Vidal et al, [19] . In our study, resolution of type 2 diabetes mellitus occurred in 70% of patients (n=35), and improvement occurred in 10% of patients (n=5).…”

Section: Discussionmentioning

confidence: 65%

See 1 more Smart Citation

Role of Laparoscopic Sleeve Gastrectomy (LSG) for Management of Obese Patients with Type 2 Diabetes Mellitus-Single Center Study

Mamdouh

2018

The Medical Journal of Cairo University

View full text Add to dashboard Cite

Background: Laparoscopic Sleeve Gastrectomy (LSG) has become one of the commonest bariatric procedures done for management of obese patients. Although Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) has well documented positive clinical influence on type 2 diabetes, the role of LSG in diabetes treatment is still questionable. In this study we want to present our experience in management of diabetes with LSG.Methods: Between September 2014 and June 2016, fifty patients were enrolled in our prospective study at Department of Surgery, Ain Shams University assessing the effect of LSG on morbid obese patients with Type 2 Diabetes Mellitus (T2DM). All patients were monitored for weight loss and improvement of T2DM markers; Fasting Blood Glucose (FBG), Postprandial Plasma Glucose (PPG) and HbA1c at 3, 6 and 12 months follow-up post-operative.Results: There was a highly significant difference between BMI at baseline and at 12 months after operation, resolution of type 2 diabetes mellitus occurred in 70% of patients evident by normalization of HbA1 c (5.6%) and stopping all medications, and improvement occurred in 10% of patients evident by HbA1c value of 6.5% without medication.Conclusion: Laparoscopic sleeve gastrectomy is simple and effective surgical procedure to achieve a significant weight loss and control of type 2 diabetes mellitus which starts in the early post-operative period. There is significant reduction in the diabetes medications hence the cost of diabetes treatment and improvement of the quality of life.

show abstract

Section: Discussionmentioning

confidence: 65%

“…In our study, the mean baseline FPG is 161mg/dl, while the mean FPG at 12 months post-operative is 102mg/dl. According to Kumar et al, the mean PPG was 208mg/dl, and 167mg/dl, at baseline and 12 months post-operatively [19] . In our study, the mean PPG declined from 232mg/dl at baseline to 149mg/dl at 12 months post-operatively.…”

Section: Discussionmentioning

confidence: 94%

Role of Laparoscopic Sleeve Gastrectomy (LSG) for Management of Obese Patients with Type 2 Diabetes Mellitus-Single Center Study

Mamdouh

2018

The Medical Journal of Cairo University

View full text Add to dashboard Cite

show abstract

Weight loss and type II diabetes control after Laparoscopic Sleeve Gastrectomy in an early post-operative period - A prospective cohort study

Cited by 1 publication

References 30 publications

Role of Laparoscopic Sleeve Gastrectomy (LSG) for Management of Obese Patients with Type 2 Diabetes Mellitus-Single Center Study

Role of Laparoscopic Sleeve Gastrectomy (LSG) for Management of Obese Patients with Type 2 Diabetes Mellitus-Single Center Study

Contact Info

Product

Resources

About